Insider Selling: David Ashley Lee Unloads 9,881 Shares of CryoLife Stock (CRY)
CryoLife (NYSE:CRY) CFO David Ashley Lee unloaded 9,881 shares of the company’s stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $10.51, for a total value of $103,849.31. Following the completion of the transaction, the chief financial officer now directly owns 228,609 shares in the company, valued at approximately $2,402,681. The transaction was disclosed in a filing with the SEC, which is available at this link.
Shares of CryoLife (NYSE:CRY) traded up 0.77% on Friday, hitting $10.43. The stock had a trading volume of 114,362 shares. CryoLife has a 1-year low of $6.01 and a 1-year high of $12.14. The stock has a 50-day moving average of $9.52 and a 200-day moving average of $9.50. The company has a market cap of $291.3 million and a price-to-earnings ratio of 19.31.
CryoLife (NYSE:CRY) last released its earnings data on Thursday, July 24th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. The company had revenue of $34.69 million for the quarter, compared to the consensus estimate of $35.72 million. During the same quarter in the previous year, the company posted $0.08 earnings per share. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, analysts predict that CryoLife will post $0.20 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, September 19th. Stockholders of record on Friday, September 12th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date of this dividend is Wednesday, September 10th.
CryoLife, Inc (NYSE:CRY) is a biological medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.